IBDEI3BS ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2015,0)
 ;;=VARICOSE VEINS^50^152
 ;;^UTILITY(U,$J,358.4,2016,0)
 ;;=WOMEN'S HEALTH^51^152
 ;;^UTILITY(U,$J,358.4,2017,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^152
 ;;^UTILITY(U,$J,358.4,2018,0)
 ;;=COMA^20^152
 ;;^UTILITY(U,$J,358.4,2019,0)
 ;;=CAUSES OF INJURY^19^152
 ;;^UTILITY(U,$J,358.4,2020,0)
 ;;=DEMENTIA^21^152
 ;;^UTILITY(U,$J,358.4,2021,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^152
 ;;^UTILITY(U,$J,358.4,2022,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^152
 ;;^UTILITY(U,$J,358.4,2023,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^152
 ;;^UTILITY(U,$J,358.4,2024,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^152
 ;;^UTILITY(U,$J,358.4,2025,0)
 ;;=ACSC ANGINA^4^152
 ;;^UTILITY(U,$J,358.4,2026,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^152
 ;;^UTILITY(U,$J,358.4,2027,0)
 ;;=ACSC CHF^6^152
 ;;^UTILITY(U,$J,358.4,2028,0)
 ;;=ACSC DEHYDRATION^7^152
 ;;^UTILITY(U,$J,358.4,2029,0)
 ;;=ACSC DIABETES TYPE 1^8^152
 ;;^UTILITY(U,$J,358.4,2030,0)
 ;;=ACSC DIABETES TYPE 2^9^152
 ;;^UTILITY(U,$J,358.4,2031,0)
 ;;=ACSC HYPERTENSION^10^152
 ;;^UTILITY(U,$J,358.4,2032,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^152
 ;;^UTILITY(U,$J,358.4,2033,0)
 ;;=ACSC PNEUMONIA^12^152
 ;;^UTILITY(U,$J,358.4,2034,0)
 ;;=ACSC UTI^13^152
 ;;^UTILITY(U,$J,358.4,2035,0)
 ;;=ACSC VIRAL ENTERITIS^14^152
 ;;^UTILITY(U,$J,358.4,2036,0)
 ;;=E-CIG/VAPE LUNG INJURY^23^152
 ;;^UTILITY(U,$J,358.4,2037,0)
 ;;=NEW PATIENT^2^153
 ;;^UTILITY(U,$J,358.4,2038,0)
 ;;=ESTABLISHED PATIENT^1^153
 ;;^UTILITY(U,$J,358.4,2039,0)
 ;;=CONSULTATIONS^3^153
 ;;^UTILITY(U,$J,358.4,2040,0)
 ;;=THERAPY MODALITIES/PROCEDURES^19^154
 ;;^UTILITY(U,$J,358.4,2041,0)
 ;;=DRUGS/MEDICATION^6^154
 ;;^UTILITY(U,$J,358.4,2042,0)
 ;;=ORTHOTIC DEVICES^13^154
 ;;^UTILITY(U,$J,358.4,2043,0)
 ;;=KINESIOTHERAPY^11^154
 ;;^UTILITY(U,$J,358.4,2044,0)
 ;;=THERAPY EVALUATIONS^18^154
 ;;^UTILITY(U,$J,358.4,2045,0)
 ;;=WOUND CARE^20^154
 ;;^UTILITY(U,$J,358.4,2046,0)
 ;;=CARDIAC REHAB^4^154
 ;;^UTILITY(U,$J,358.4,2047,0)
 ;;=EDUCATION/TRAINING^7^154
 ;;^UTILITY(U,$J,358.4,2048,0)
 ;;=HOME THERAPY SERVICES^9^154
 ;;^UTILITY(U,$J,358.4,2049,0)
 ;;=NEUROMUSCULAR TESTING^12^154
 ;;^UTILITY(U,$J,358.4,2050,0)
 ;;=TEAM CONFERENCE^16^154
 ;;^UTILITY(U,$J,358.4,2051,0)
 ;;=HEALTH BEHAVIORS^8^154
 ;;^UTILITY(U,$J,358.4,2052,0)
 ;;=RECREATION THERAPY^14^154
 ;;^UTILITY(U,$J,358.4,2053,0)
 ;;=DEVICES/SUPPLIES^5^154
 ;;^UTILITY(U,$J,358.4,2054,0)
 ;;=TENS^17^154
 ;;^UTILITY(U,$J,358.4,2055,0)
 ;;=ACUPUNCTURE^1^154
 ;;^UTILITY(U,$J,358.4,2056,0)
 ;;=INJECTIONS^10^154
 ;;^UTILITY(U,$J,358.4,2057,0)
 ;;=SPINAL CORD STIMULATOR^15^154
 ;;^UTILITY(U,$J,358.4,2058,0)
 ;;=ADAPTIVE BEHAVIOR ASSESSMENTS^2^154
 ;;^UTILITY(U,$J,358.4,2059,0)
 ;;=ADAPTIVE BEHAVIOR TREATMENT^3^154
 ;;^UTILITY(U,$J,358.4,2060,0)
 ;;=AMPUTATION STATUS^1^155
 ;;^UTILITY(U,$J,358.4,2061,0)
 ;;=BRAIN DISORDERS^2^155
 ;;^UTILITY(U,$J,358.4,2062,0)
 ;;=CARDIOPULMONARY^4^155
 ;;^UTILITY(U,$J,358.4,2063,0)
 ;;=COMPLICATIONS DUE TO^5^155
 ;;^UTILITY(U,$J,358.4,2064,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^12^155
 ;;^UTILITY(U,$J,358.4,2065,0)
 ;;=Z CODES^21^155
 ;;^UTILITY(U,$J,358.4,2066,0)
 ;;=BRAIN INJURY - TRAUMATIC^3^155
 ;;^UTILITY(U,$J,358.4,2067,0)
 ;;=FEMUR/THIGH/KNEE FRACTURE^7^155
 ;;^UTILITY(U,$J,358.4,2068,0)
 ;;=FOOT/TOE/ANKLE FRANCTURE^8^155
 ;;^UTILITY(U,$J,358.4,2069,0)
 ;;=HAND/FINGER FRACTURE^9^155
 ;;^UTILITY(U,$J,358.4,2070,0)
 ;;=HIP/PELVIS FRACTURE^10^155
